HFREF - HEART FAILURE WITH REDUCED EJECTION FRACTION
Clinical trials for HFREF - HEART FAILURE WITH REDUCED EJECTION FRACTION explained in plain language.
Never miss a new study
Get alerted when new HFREF - HEART FAILURE WITH REDUCED EJECTION FRACTION trials appear
Sign up with your email to follow new studies for HFREF - HEART FAILURE WITH REDUCED EJECTION FRACTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Heart failure drug study pulled before starting
Disease control TerminatedThis study was designed to test the safety and tolerability of a drug called JK07 in people with heart failure and a specific type of high blood pressure in the lungs. It planned to enroll 20 to 30 adults aged 18 to 85. However, the study was withdrawn before any participants wer…
Matched conditions: HFREF - HEART FAILURE WITH REDUCED EJECTION FRACTION
Phase: PHASE2 • Sponsor: Salubris Biotherapeutics Inc • Aim: Disease control
Last updated May 17, 2026 06:50 UTC
-
Can a smartphone app help heart patients take the right dose?
Knowledge-focused ENROLLING_BY_INVITATIONThis study tests whether a phone app called StudyU can help people with heart failure reach the recommended dose of their beta blocker medicine. Five adults aged 65 and older with heart failure will use the app. The goal is to see if the app is practical and acceptable for patien…
Matched conditions: HFREF - HEART FAILURE WITH REDUCED EJECTION FRACTION
Phase: PHASE4 • Sponsor: Weill Medical College of Cornell University • Aim: Knowledge-focused
Last updated May 14, 2026 12:05 UTC